Target intelligence / Profile preview

Viral structural protein

Molecular classification
Other (category/class), Capsid protein, Envelope protein, Nucleocapsid protein, Glycoprotein, Viral polyprotein
01

Overview

Viral structural proteins are components of mature virus particles, forming the physical structure (capsid, envelope, glycoprotein spikes, etc.) and playing key roles in viral assembly, stability, host cell entry, and immune evasion. The class includes capsid proteins that enclose the viral genome, envelope proteins that facilitate membrane fusion, and glycoprotein spikes that mediate host cell receptor binding. Some structural proteins (e.g., nucleocapsid) are also involved in genome packaging and replication. Although often targeted by vaccines and antiviral drugs (such as fusion inhibitors), the term "viral structural protein" is generic and does not denote a specific protein target, making it less suitable for precise molecular targeting or drug development. For therapeutic intent, it is important to specify the particular viral protein (e.g., "HIV-1 gp41" or "SARS-CoV-2 spike protein") rather than the general class.

Other names
Structural viral proteinVirion structural proteinCapsid proteinEnvelope proteinGlycoprotein spikeNucleocapsid protein
02

Mechanism of action

Inhibition of viral fusion (e.g., enfuvirtide); Vaccination by induction of protective immunity against viral capsid proteins

03

Biological functions

Structural integrityAssembly of virus particleGenome protectionHost cell entryImmune evasion
04

Disease associations

InfectionPathogenicityImmune response modulation
05

Safety considerations

Risk of antigenic variation leading to resistance or immune escapeLimited specificity for targeted therapy due to diversity among viral species
06

Interacting drugs

Enfuvirtide (HIV-1 gp41 fusion inhibitor)

2 more in the full profile.

07

Biomarkers

Viral capsid antigens (for diagnostic serology)Envelope glycoprotein antigens (for diagnostic serology)

Beyond the preview

Go deeper on Viral structural protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral structural protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call